FDA Approves BiDil Heart Failure Drug for Black Patients. The Food and Drug Administration (FDA) approved BiDil (bye-DILL), a drug for the treatment of ...
BiDil contains a combination of hydralazine and isosorbide dinitrate. Hydralazine is a vasodilator. It relaxes (widens) veins and arteries, which makes it easier for ...
BiDil is a fixed-dose combination of isosorbide dinitrate, a vasodilator with effects on both arteries and veins, and hydralazine hydrochloride, a predominantly ...
Find patient medical information for BiDil oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
I am a health care provider interested in providing BiDil to my patients · I am a patient/caregiver interested in learning about BiDil for African Americans with ...
bidil (isosorbide dinitrate and hydralazine hydrochloride) tablet, film coated [NitroMed, Inc.] DESCRIPTION. BiDil is a fixed-dose combination of isosorbide dinitrate ...
BiDil is used with other medications in self-identified black patients to improve survival, to prolong time to hospitalization for heart failure, and to improve ...
Isosorbide dinitrate/hydralazine is a fixed dose combination drug treatment specifically indicated for African Americans with congestive heart failure.
BiDil is a combination of isosorbide dinitrate, a nitrate vasodilator, and hydralazine hydrochloride, an arteriolar vasodilator, indicated for:
General Information. BiDil is a single-pill, fixed-dose combination of two generic drugs, isosorbide dinitrate and hydralazine hydrochloride. The combination exerts ...